Health Care [ 9/12 ] | Health Care Providers & Services [ 8/74 ]
NYSE | Common Stock
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide.
The company operates in two segments, Products & Healthcare Services and Patient Direct.
The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Its portfolio of medical and surgical supplies includes branded products and its proprietary products.
This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers.
The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment.
This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services.
The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors.
Accendra Health, Inc. was formerly known as Owens & Minor, Inc. and changed its name Accendra Health, Inc. in December 2025.
The company was founded in 1882 and is based in Glen Allen, Virginia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| May 1, 26 | 0.00 Decreased by -100.00% | 0.14 Decreased by -100.00% |
| Feb 25, 26 | 0.00 Decreased by -100.00% | 0.22 Decreased by -100.00% |
| Oct 30, 25 | 0.25 Decreased by -40.48% | 0.24 Increased by +5.93% |
| Aug 11, 25 | 0.26 Decreased by -27.78% | 0.29 Decreased by -10.34% |
| May 1, 25 | 0.23 Increased by +21.05% | 0.20 Increased by +14.43% |
| Feb 18, 25 | 0.55 Decreased by -20.29% | 0.52 Increased by +5.67% |
| Nov 4, 24 | 0.42 Decreased by -4.55% | 0.41 Increased by +2.44% |
| Aug 2, 24 | 0.36 Increased by +100.00% | 0.33 Increased by +9.09% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | -1.25 B Decreased by -146.33% | -56.33 M Increased by +80.98% | Increased by +4.51% Increased by +141.05% |
| Sep 30, 25 | 697.26 M Increased by +1.52% | -150.28 M Decreased by -1.08 K% | Decreased by -21.55% Decreased by -1.06 K% |
| Jun 30, 25 | 681.92 M Increased by +3.26% | -869.06 M Decreased by -2.62 K% | Decreased by -127.44% Decreased by -2.54 K% |
| Mar 31, 25 | 2.63 B Increased by +312.65% | -24.98 M Decreased by -14.15% | Decreased by -0.95% Increased by +72.34% |
| Dec 31, 24 | 2.70 B Increased by +1.50% | -296.12 M Decreased by -1.77 K% | Decreased by -10.98% Decreased by -1.74 K% |
| Sep 30, 24 | 686.85 M Decreased by -73.50% | -12.77 M Decreased by -98.72% | Decreased by -1.86% Decreased by -649.86% |
| Jun 30, 24 | 660.40 M Decreased by -74.24% | -31.91 M Decreased by -13.00% | Decreased by -4.83% Decreased by -338.60% |
| Mar 31, 24 | 637.84 M Decreased by -74.72% | -21.89 M Increased by +10.37% | Decreased by -3.43% Decreased by -254.51% |